๐ฌ Current Disease Focus:
Task Progress: 0%
๐ฅ Active Problem Solvers
0
๐ Experts collaborating globally
โก Current Task Assignment
๐งฌ Genetic Analysis
๐ Matching experts to specific tasks
๐ Resource Allocation by Research Phase:
๐ Data Analysis
๐งช Experimental Design
๐ฌ Clinical Trials
๐ Treatment Development
This phase I/II trial studies the side effects and best dose of linsitinib ...
Status
Withdrawn
Location
OHSU Knight Cancer Institute
Start Date
2011-12
Trial ID
NCT01465815
The primary objective of this study is to determine if the combination regi...
Status
Terminated
Location
Multiple Locations
Start Date
2011-07
Trial ID
NCT01377376
Treatments Being Tested
This trial was originally designed and powered to compare biomarker modulat...
Status
Completed
Location
University of Pittsburgh Cancer Institute
Start Date
2005-11
Trial ID
NCT01515137
Treatments Being Tested
This ALCHEMIST trial studies genetic testing in screening patients with sta...
Status
Active Not Recruiting
Location
University of Alabama at Birmingham Cancer Center
Start Date
2014-09-26
Trial ID
NCT02194738
Treatments Being Tested
This 4 arm study in patients with advanced Stage IIIb/IV non-small cell can...
Status
Terminated
Location
Tower Cancer Research Foundation
Start Date
2008-11-10
Trial ID
NCT00760929
Treatments Being Tested
The investigators hypothesized that topical anti-inflammatory treatment cou...
Status
Completed
Location
Davidoff Center, Rabin Medical Center, Beilinson
Start Date
2011-01
Trial ID
NCT01256437
Treatments Being Tested
This phase III ALCHEMIST trial studies how well erlotinib hydrochloride com...
Status
Active Not Recruiting
Location
University of Alabama at Birmingham Cancer Center
Start Date
2015-02-11
Trial ID
NCT02193282
This randomized, placebo-controlled, Phase II trial will compare the combin...
Status
Completed
Location
Florida Cancer Specialists
Start Date
2010-01
Trial ID
NCT01027598
This randomized phase II trial is studying how well erlotinib hydrochloride...
Status
Completed
Location
VA Long Beach Healthcare System
Start Date
2008-07
Trial ID
NCT00754494
Treatments Being Tested
This phase II randomized placebo-controlled trial studies low-dose erlotini...
Status
Not Yet Recruiting
Location
UT Southwestern Medical Center
Start Date
2026-12
Trial ID
NCT04172779
Treatments Being Tested